1,4-Diaza-bicyclo[3.2.2]nonane-4-carboxylic acid 4'-methoxy-biphenyl-4-yl ester

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1,4-Diaza-bicyclo[3.2.2]nonane-4-carboxylic acid 4'-methoxy-biphenyl-4-yl ester
• 英文别名: [4-(4-Methoxyphenyl)phenyl] 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate
• 化学式: C₂₁H₂₄N₂O₃
• 分子量: 352.433
• InChiKey: WMFIMGIFIULJEH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  42
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• Pharmaceutical compositions for the treatment of CNS and other discorders
  申请人：Pfizer Inc.

  公开号：US20020177591A1

  公开（公告）日：2002-11-28

  The present invention relates to a method of treating disorders of the central nervous system (CNS) and other disorders in a mammal, including a human, by administering to the mammal a CNS-penetrant &agr;7 nicotinic receptor agonist. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier and a CNS-penetrant &agr;7 nicotinic receptor agonist.

  本发明涉及一种治疗哺乳动物（包括人类）中枢神经系统（CNS）和其他疾病的方法，通过向哺乳动物施用一种穿透中枢神经系统的α7尼古丁受体激动剂。还涉及含有药用载体和穿透中枢神经系统的α7尼古丁受体激动剂的药物组合物。
• Pharmaceutical compositions for the treatment of CNS and other disorders
  申请人：O'Donnell J. Christopher

  公开号：US20060014750A1

  公开（公告）日：2006-01-19

  The present invention relates to a method of treating disorders of the central nervous system (CNS) and other disorders in a mammal, including a human, by administering to the mammal a CNS-penetrant α7 nicotinic receptor agonist. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier and a CNS-penetrant α7 nicotinic receptor agonist.

  本发明涉及一种通过给哺乳动物，包括人类，投与中枢神经系统（CNS）和其他疾病的治疗方法，其中包括给哺乳动物投与一种CNS渗透性α7尼古丁受体激动剂。同时，本发明还涉及含有药用载体和CNS渗透性α7尼古丁受体激动剂的制药组合物。
• Pharmaceutical compositions for the treatment of disorders of the CNS and other disorders
  申请人：Pfizer Products Inc.

  公开号：EP1231212A1

  公开（公告）日：2002-08-14

  The present invention relates to a method of treating disorders of the central nervous system (CNS) and other disorders in a mammal, including a human, by administering to the mammal a CNS-penetrant α7 nicotinic receptor agonist. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier and a CNS-penetrant α7 nicotinic receptor agonist.

  本发明涉及一种治疗哺乳动物（包括人类）中枢神经系统（CNS）紊乱和其他疾病的方法，其方法是向哺乳动物施用中枢神经系统拮抗剂α7烟碱受体激动剂。它还涉及含有药学上可接受的载体和中枢神经系统穿透性α7烟碱受体激动剂的药物组合物。